Literature DB >> 17337162

Effect of antipsychotics on pituitary gland volume in treatment-naïve first-episode schizophrenia: a pilot study.

Frank P MacMaster1, Rhonda El-Sheikh, Ameet R Upadhyaya, Jeffrey Nutche, David R Rosenberg, Matcheri Keshavan.   

Abstract

The objective of this study was to examine the effect of antipsychotics on pituitary volume in schizophrenic subjects. Pituitary volumes were measured in 16 patients with schizophrenia at baseline and 12 months after treatment with an antipsychotic medication using magnetic resonance imaging (MRI). A group of 12 healthy controls was evaluated at baseline and after 12 months. Pituitary volume significantly increased in the schizophrenic subjects after treatment (12% increase). This appeared to be specific to the prolactin-elevating drugs. In controls, pituitary volume did not change significantly (3% decrease). Pituitary volume may be a useful biomarker for treatments that affect neuroendocrine function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337162     DOI: 10.1016/j.schres.2007.01.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

Review 1.  Pituitary gland in psychiatric disorders: a review of neuroimaging findings.

Authors:  Murad Atmaca
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 2.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

3.  Pituitary volume in schizophrenia spectrum disorders.

Authors:  F Romo-Nava; W S Hoogenboom; P E Pelavin; J L Alvarado; L H Bobrow; F P Macmaster; M Keshavan; R W McCarley; M E Shenton
Journal:  Schizophr Res       Date:  2013-03-19       Impact factor: 4.939

4.  Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Marcus Schiltenwolf
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

5.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

6.  Pituitary lacks sexual dimorphism and displays reduced signal intensity on T1-weighted MRI in adolescents with histories of heavy prenatal alcohol exposure.

Authors:  Eileen M Moore; M Alejandra Infante; Robyn Migliorini; Sarah N Mattson; Edward P Riley
Journal:  Neurotoxicol Teratol       Date:  2016-09-09       Impact factor: 3.763

7.  Pituitary volumes in relatives of bipolar patients: high-risk study.

Authors:  Tomas Hajek; Eva Gunde; Denise Bernier; Claire Slaney; Lukas Propper; Glenda Macqueen; Anne Duffy; Martin Alda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

8.  Pituitary volume in first-episode schizophrenia.

Authors:  Patricia Gruner; Christopher Christian; Delbert G Robinson; Serge Sevy; Handan Gunduz-Bruce; Barbara Napolitano; Robert M Bilder; Philip R Szeszko
Journal:  Psychiatry Res       Date:  2012-08-02       Impact factor: 3.222

9.  Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways.

Authors:  H L Cai; P Jiang; Q Y Tan; R L Dang; M M Tang; Y Xue; Y Deng; B K Zhang; P F Fang; P Xu; D X Xiang; H D Li; J K Yao
Journal:  Transl Psychiatry       Date:  2017-05-16       Impact factor: 6.222

10.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.